| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Revance Therapeutics Inc (NASDAQ: RVNC)
RVNC Technical Analysis
5
| As on 6th Feb 2025 RVNC STOCK Price closed @ 3.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 6.97 & Strong Sell for SHORT-TERM with Stoploss of 12.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RVNCSTOCK Price
| Open | 3.65 | Change | Price | % |
| High | 3.65 | 1 Day | 0.00 | 0.00 |
| Low | 3.65 | 1 Week | 0.00 | 0.00 |
| Close | 3.65 | 1 Month | 0.56 | 18.12 |
| Volume | N/A | 1 Year | -13.90 | -79.20 |
| 52 Week High 18.61 | 52 Week Low 2.34 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 157.75 | 1.76% |
| HCTI | 0.02 | -33.33% |
| LCID | 2.12 | -3.64% |
| OPEN | 0.56 | 3.70% |
| LMDX | 0.02 | 0.00% |
| AMZN | 223.30 | 2.85% |
| GOOGL | 178.53 | 2.88% |
| AKTS | 0.04 | 0.00% |
| INTC | 22.69 | 0.84% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RVNC Daily Charts |
RVNC Intraday Charts |
Whats New @ Bazaartrend |
RVNC Free Analysis |
|
|
RVNC Important Levels Intraday
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
| RESISTANCE | 3.65 |
RVNC Forecast June 2025
| 4th UP Forecast | 13.44 |
| 3rd UP Forecast | 10.3 |
| 2nd UP Forecast | 8.36 |
| 1st UP Forecast | 6.42 |
| 1st DOWN Forecast | 0.88 |
| 2nd DOWN Forecast | -1.06 |
| 3rd DOWN Forecast | -3 |
| 4th DOWN Forecast | -6.14 |
RVNC Weekly Forecast
| 4th UP Forecast | 8.04 |
| 3rd UP Forecast | 6.63 |
| 2nd UP Forecast | 5.76 |
| 1st UP Forecast | 4.89 |
| 1st DOWN Forecast | 2.41 |
| 2nd DOWN Forecast | 1.54 |
| 3rd DOWN Forecast | 0.67 |
| 4th DOWN Forecast | -0.74 |
RVNC Forecast2025
| 4th UP Forecast | 35.85 |
| 3rd UP Forecast | 25.52 |
| 2nd UP Forecast | 19.14 |
| 1st UP Forecast | 12.76 |
| 1st DOWN Forecast | -5.46 |
| 2nd DOWN Forecast | -11.84 |
| 3rd DOWN Forecast | -18.22 |
| 4th DOWN Forecast | -28.55 |
Revance Therapeutics Inc ( NASDAQ USA Symbol : RVNC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RVNC Business Profile
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to treat upper facial lines, moderate or severe dynamic forehead lines, and moderate or severe lateral canthal lines; and has completed Phase II clinical trials for the treatment of adult upper limb spasticity and plantar fasciitis. It is also developing DAXI in preclinical trial for the treatment of migraine, as well as a topical program for various indications; and OnabotulinumtoxinA, a biosimilar to BOTOX. The company has a collaboration and license agreement with Viatris Inc. for the development and regulatory approval of a biosimilar to BOTOX. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was incorporated in 1999 and is headquartered in Newark, California. Address: 1222 Demonbreun Street, Newark, CA, United States, 37203
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service